Nurix Therapeutics (NRIX) Other Working Capital Changes (2019 - 2026)

Nurix Therapeutics (NRIX) has 8 years of Other Working Capital Changes data on file, last reported at $900000.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 164.29% year-over-year to $900000.0 in Q2 2026; TTM through May 2026 was -$34.3 million, a 43.0% decrease from a year earlier, with the FY2025 full-year figure at -$37.0 million, down 29.53% from the prior year.
• Other Working Capital Changes for Q2 2026 stood at $900000.0, up from -$1.3 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for NRIX reached as high as $6.3 million in Q1 2025 and fell as low as -$3.3 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged $227388.9 across 5 years, with a median of $209000.0 in 2022.
• Across the five-year window, Other Working Capital Changes surged 210.65% in 2022 and tumbled 900.3% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at $17.5 million in 2022, then plunged by 107.6% to -$1.3 million in 2023, then tumbled by 900.3% to -$13.3 million in 2024, then tumbled by 145.93% to -$32.7 million in 2025, then surged by 102.75% to $900000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $900000.0 in Q2 2026, -$1.3 million in Q1 2026, and -$32.7 million in Q4 2025.